Canadian doctor William Makis: $2 a pill MEBENDAZOLE kills ovarian cancer cells resistant to chemotherapy…”once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent”

August 26, 2024

According to Canadian Dr William Makis, Mebendazole was able to inhibit and kill ovarian cancer cells that were resistant to cisplatin chemotherapy.

Makis adds: “Almost identical to Fenbendazole, a drug being repurposed to treat Turbo Cancers caused by Pfizer and Moderna COVID-19 mRNA Vaccines, Mebendazole is also being repurposed for CANCER.”

NEW ARTICLE: MEBENDAZOLE kills Ovarian Cancer Cells that are resistant to Chemotherapy – once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent

2021 paper by Huang – Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human… pic.twitter.com/SgOXGTyCRh
— William Makis MD (@MakisMD) August 25, 2024

Canadian doctor William Makis: $2 a pill MEBENDAZOLE kills ovarian cancer cells resistant to chemotherapy…”once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent”

Related Posts